von Tobias Borgers | Juli 5, 2022 | Bayer
Berlin / Boston, 29. Juni 2022 – Die Bayer AG gab heute die Eröffnung ihres neuen Forschungs- und Innovationszentrums am Kendall Square in Boston-Cambridge, Massachusetts (USA) bekannt. Mit dem Zentrum baut das Unternehmen seine Präsenz an einem der weltweit...
von Tobias Borgers | Juli 5, 2022 | Bayer
Global pharmaceutical and life sciences company Bayer is eyeing the growing market for over-the-counter (OTC) products in India. The consumer health division of Bayer in India, that recently launched the new product Saridon Advance for severe headaches, is planning to...
von Tobias Borgers | Juni 21, 2022 | Boehringer
Companies to research Antibody-Drug Conjugates (ADC) to address cancers of high unmet need Collaboration to utilize ImmunoGen’s ADC linker-payload technology directed to targets identified by OBT Each company may select a number of pre-clinical programs for...
von Tobias Borgers | Juni 7, 2022 | Boehringer
LH Mikl-Leitner: „Das größte Ansiedlungsprojekt in der Geschichte unseres Bundeslandes“ St. Pölten (OTS/NLK) – Das weltweit erfolgreiche Unternehmen Boehringer Ingelheim hat entschieden, eine neue Produktionsstätte in Niederösterreich zu errichten. Damit werden...
von Tobias Borgers | Mai 25, 2022 | Tablet Coating
3D printing has the potential to revolutionise the pharmaceutical manufacturing industry; however, few 3D-printed products have been approved since the first in 2015. In this article, EPR’s Hannah Balfour explores the technologies currently being evaluated for use in...
